Ares Financial Consulting
GSK icon

Ares Financial Consulting’s GSK GSK Stock Holding History

Ares Financial Consulting’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.82K Buy
183
+102
+126% +$5.21K 0.01% 585
2026
Q2 		$4.25K Buy
81
+47
+138% +$2.49K ﹤0.01% 752
2026
Q1 		$1.9K Hold
34
– – ﹤0.01% 852
2025
Q4 		$1.67K Buy
+34
New +$1.59K ﹤0.01% 684

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Ares Financial Consulting's GSK Position: Q3 2026 in Review

Ares Financial Consulting increased its GSK (GSK) stake by 126% in Q3 2026, buying an estimated $5.21K and bringing the position to 183 shares worth $8.82K. The position accounts for 0.01% of the portfolio, ranked #585.

Ares Financial Consulting first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. 558 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Ares Financial Consulting held 183 shares of GSK worth $8.82K as of Q3 2026.
  • Ares Financial Consulting bought 102 GSK shares in Q3 2026, an estimated $5.21K.
  • GSK made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #585 holding.
  • Ares Financial Consulting first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • 558 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.